ISU Chemical 2026 Q1: Turnaround to Profit and Improved Financial Structure

Consolidated revenue for Q1 2026: KRW 635.8 billion, operating profit KRW 25.4 billion (turnaround from loss)
Net profit KRW 20.8 billion (vs. net loss of KRW 40.5 billion for full year 2025)
Debt ratio: 164% (down from 305% at end-2025); net debt ratio: 58% (down from 156%)
Cash and cash equivalents: KRW 146.2 billion (up from KRW 75.6 billion)
Petrochemical segment revenue up 58% YoY, operating profit KRW 23.3 billion
Construction segment operating profit KRW 5.6 billion; Pharma segment operating loss KRW 3.4 billion
Sanctions: Customs fine of KRW 886 million paid; 1-month suspension of Clotinab Phase 3 trial

ADVERTISEMENT (250px+)